Popular GLP-1 drugs significantly reduce major cardiovascular events,
View as a Web Page
News Medical
 
  Cardiology Cardiology logo  
  The latest cardiology news from News Medical  
 Two leading heart risk tools pass a major global testTwo leading heart risk tools pass a major global test
 
A multinational Nature Medicine validation study found that PREVENT and SCORE2 cardiovascular risk equations performed generally well across 6.4 million people from observational cohorts and randomized trials. The findings support broader use of these tools for CVD risk stratification, while highlighting the need for local calibration and more validation in underrepresented regions.
 
 
 Popular GLP-1 drugs significantly reduce major cardiovascular events,Popular GLP-1 drugs significantly reduce major cardiovascular events,
 
Researchers evaluate the long-term cardiovascular safety and efficacy of GLP-1RAs in high-risk populations.
 
   App launched to track heart health after high-risk pregnanciesApp launched to track heart health after high-risk pregnancies
 
The MumCare app addresses postpartum cardiovascular risk, supporting women in managing health after pregnancy complications through personalized digital tools.
 
   A new tool that predicts obesity-related disease risk beyond BMIA new tool that predicts obesity-related disease risk beyond BMI
 
OBSCORE is a data-driven tool that identifies high-risk individuals for obesity-related diseases, enhancing treatment targeting beyond traditional BMI metrics.
 
   AI-powered MRI scans predict diabetes and heart disease riskAI-powered MRI scans predict diabetes and heart disease risk
 
Research shows AI-enhanced MRI body composition metrics can predict diabetes and heart disease risks, offering insights for better health screening practices.
 
 Brain artery widening may drive lacunar stroke more than artery narrowing
 
Brain artery widening may drive lacunar stroke more than artery narrowingAbnormal brain artery widening is associated with lacunar stroke, indicating a shift in understanding the mechanisms behind small vessel disease in the brain.
 
 
 Ultra processed foods linked to higher cardiovascular disease and death
 
Ultra processed foods linked to higher cardiovascular disease and deathPeople who eat more ultra processed food (UPF) have a higher risk of cardiovascular disease and death, according to a report published in the European Heart Journal today (Thursday).
 
 
 Urges for cardiologists to screen patients for UPF intake
 
Urges for cardiologists to screen patients for UPF intakeThe European Society of Cardiology identifies ultra-processed foods as a key cardiovascular risk, urging a shift in dietary guidelines for better heart health.
 
 
 New ‘heart-on-a-chip’ to halt cardiac damage caused by Duchenne
 
Duchenne Parent Project Spain (DPPE) has launched the BEAT Project, a research initiative focused on one of the key challenges associated with Duchenne and Becker muscular dystrophies: progressive heart damage. Cardiomyopathy is the leading cause of death in patients with DMD.
 
 
 Advanced 3D heart models could transform cardiovascular drug discovery
 
Advanced 3D heart models could transform cardiovascular drug discoveryCardiovascular disease remains a leading global health burden, yet many preclinical systems still struggle to predict how candidate drugs will perform in the human heart.
 
 
 AI models predict sudden cardiac arrest risk using health records
 
Researchers have developed artificial intelligence (AI) models that can scrutinize electronic health records (EHR) and electrocardiograms to identify individuals in the general population at elevated risk for sudden cardiac arrest - a condition that causes more than 400,000 U.S. deaths annually and has a survival rate of only 10%.
 
 
 New model improves outcome predictions for patients with hypertrophic cardiomyopathy
 
New model improves outcome predictions for patients with hypertrophic cardiomyopathyFindings from a study supported in part by the National Institutes of Health (NIH) have identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM), a heart condition with a prevalence of 1 in 500 people and a frequent cause of sudden cardiac death.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026